"lepra, leprosy" 是什么意思，中文意思 | 大麻风英文怎么说医学英语中英文词汇翻译

[PDF] Adverse effects of Multi-drug therapy in leprosy, a two years' experience (2006–2008) in tertiary health care centre in the tribal region of Chhattisgarh state ( …

[PDF] from leprahealthinaction.orgH SINGH, B NEL, V DEY, P TIWARI… - Leprosy …, 2011 - leprahealthinaction.org
... Lepr Rev (2011) 82, 17–24 0305-7518/11/064053+08 $1.00 q Lepra 17 Page 2. ... Exclusion criteria:
Those, who had taken any other medication during this study, Patients with any other chronic
illness Those who had interrupted the MDT medication Patient with lepra reaction ...
Related articles - View as HTML - All 3 versions

[PDF] Relapse study in smear positive multibacillary (MB) leprosy after 1 year WHO-multi-drug therapy (MDT) in Cebu, Philippines

[PDF] from leprahealthinaction.orgA MAGHANOY, I MALLARI, M BALAGON… - Leprosy …, 2011 - leprahealthinaction.org
... Lepr Rev (2011) 82, 65–69 0305-7518/11/064053+05 $1.00 q Lepra 65 ... Subjects were also
encouraged to report to the clinic between scheduled visits for unusual skin problems, including
Type 1 (reversal; RR) or Type 2 (erythema nodosum leprosum; ENL) lepra reactions. ...
Related articles - View as HTML - All 3 versions

[PDF] Qualitative Assessment of Medication Adherence at an Urban Leprosy Outpatient Clinic in Hyderabad, India

[PDF] from leprahealthinaction.orgD WEIAND, WC SMITH… - Leprosy review, 2011 - leprahealthinaction.org
... Lepr Rev (2011) 82, 70–73 70 0305-7518/11/064053+04 $1.00 q Lepra Page 2. ... FUNDING LEPRA,
the British Association of Dermatologists (BAD) and the University of Aberdeen's Alumni Annual
Fund all contributed towards the funding of this medical elective. ...
Related articles - View as HTML - All 3 versions

[PDF] Fighting diseases of poverty

[PDF] from leprahealthinaction.orgBLN Cards - Women, 2011 - leprahealthinaction.org
The following article, on the use of thalidomide in the treatment of leprosy, appeared in the WHO
Pharmaceuticals Newsletter, No. 2, 2003, and can be found on the WHO website (http://www.
who.int/ lep/TAG/Thal.doc). The article is followed by three commentaries on Dr ...
Related articles - View as HTML - All 4 versions

[PDF] Bilateral medial fingernail dystrophy as a presenting feature in a patient with leprosy

[PDF] from leprahealthinaction.orgP BHUSHAN, A AGGARWAL, R YADAV… - Leprosy …, 2011 - leprahealthinaction.org
... Correspondence to: Premanshu Bhushan, Skin Institute and School of Dermatology, N-block,
Greater Kailash-1, New Delhi-110048, India (e-mail: drpremanshu@gmail.com) Lepr Rev (2011)
82, 74–77 74 0305-7518/11/064053+04 $1.00 q Lepra Page 2. sought. ...
Related articles - View as HTML - All 3 versions

[PDF] Adverse effects of Multi-drug therapy in leprosy, a two years' experience (2006–2008) in tertiary health care centre in the tribal region of Chhattisgarh state ( …

[PDF] from leprahealthinaction.orgH SINGH, B NEL, V DEY, P TIWARI… - Leprosy …, 2011 - leprahealthinaction.org
... Lepr Rev (2011) 82, 17–24 0305-7518/11/064053+08 $1.00 q Lepra 17 Page 2. ... Exclusion criteria:
Those, who had taken any other medication during this study, Patients with any other chronic
illness Those who had interrupted the MDT medication Patient with lepra reaction ...
Related articles - View as HTML - All 3 versions

[PDF] Relapse study in smear positive multibacillary (MB) leprosy after 1 year WHO-multi-drug therapy (MDT) in Cebu, Philippines

[PDF] from leprahealthinaction.orgA MAGHANOY, I MALLARI, M BALAGON… - Leprosy …, 2011 - leprahealthinaction.org
... Lepr Rev (2011) 82, 65–69 0305-7518/11/064053+05 $1.00 q Lepra 65 ... Subjects were also
encouraged to report to the clinic between scheduled visits for unusual skin problems, including
Type 1 (reversal; RR) or Type 2 (erythema nodosum leprosum; ENL) lepra reactions. ...
Related articles - View as HTML - All 3 versions

[PDF] Qualitative Assessment of Medication Adherence at an Urban Leprosy Outpatient Clinic in Hyderabad, India

[PDF] from leprahealthinaction.orgD WEIAND, WC SMITH… - Leprosy review, 2011 - leprahealthinaction.org
... Lepr Rev (2011) 82, 70–73 70 0305-7518/11/064053+04 $1.00 q Lepra Page 2. ... FUNDING LEPRA,
the British Association of Dermatologists (BAD) and the University of Aberdeen's Alumni Annual
Fund all contributed towards the funding of this medical elective. ...
Related articles - View as HTML - All 3 versions

[PDF] Fighting diseases of poverty

[PDF] from leprahealthinaction.orgBLN Cards - Women, 2011 - leprahealthinaction.org
The following article, on the use of thalidomide in the treatment of leprosy, appeared in the WHO
Pharmaceuticals Newsletter, No. 2, 2003, and can be found on the WHO website (http://www.
who.int/ lep/TAG/Thal.doc). The article is followed by three commentaries on Dr ...
Related articles - View as HTML - All 4 versions

[PDF] Bilateral medial fingernail dystrophy as a presenting feature in a patient with leprosy

[PDF] from leprahealthinaction.orgP BHUSHAN, A AGGARWAL, R YADAV… - Leprosy …, 2011 - leprahealthinaction.org
... Correspondence to: Premanshu Bhushan, Skin Institute and School of Dermatology, N-block,
Greater Kailash-1, New Delhi-110048, India (e-mail: drpremanshu@gmail.com) Lepr Rev (2011)
82, 74–77 74 0305-7518/11/064053+04 $1.00 q Lepra Page 2. sought. ...
Related articles - View as HTML - All 3 versions

Increased CXC Ligand 10 Levels and Gene Expression in Type 1 Leprosy Reactions

DM Scollard, MV Chaduvula… - Clinical and Vaccine …, 2011 - Am Soc Microbiol
Type 1 reaction (T1R) is a systemic inflammatory syndrome causing substantial morbidity in
leprosy. T1R results from spontaneously enhanced cellular immunity in borderline types of
leprosy, but there are no established laboratory markers for the reaction. Preliminary ...
Related articles - All 3 versions

Genetic Variations and Interactions in Anti-inflammatory Cytokine Pathway Genes in the Outcome of Leprosy: A Study Conducted on a MassARRAY Platform

S Aggarwal, S Ali, R Chopra… - Journal of Infectious …, 2011 - jid.oxfordjournals.org
Methods. We investigated the association of 51 single-nucelotide polymorphisms (SNPs) in
anti-inflammatory cytokines (IL-10, TGFB1, IL-6, IL-4, and IL-13) and receptors (IL-10RA,
IL-10RB, TGFBR1, TGFBR2, IL-6R, IL-4R, IL-5RA, IL-5RB, and IL-13RA1) with ...

Specific IgG antibody responses may be used to monitor leprosy treatment efficacy and as recurrence prognostic markers

[PDF] from ufu.brMS Duthie, MN Hay, EM Rada, J Convit… - European Journal of …, 2011 - Springer
Abstract Although curable, leprosy requires better diagnostic and prognostic tools to
accompany therapeutic strategies. We evaluated the serum samples of leprosy patients from
Venezuela and Brazil for reactivity against the specific recombinant proteins, ML0405 and ...
Related articles - All 4 versions

Human Leukocyte Antigen Class I Region Single-Nucleotide Polymorphisms are Associated with Leprosy Susceptibility in Vietnam and India

A Alter, NT Huong, M Singh… - Journal of Infectious …, 2011 - jid.oxfordjournals.org
Experimental evidence suggested the existence of unidentified leprosy susceptibility loci in the
human leukocyte antigen (HLA) complex. To identify such genetic risk factors, a high-density
association scan of a 1.9-mega-base (Mb) region in the HLA complex was performed. ...
Cited by 4 - Related articles - All 4 versions

Leprosy control: knowledge shall not be neglected

MLF Penna, JG Temporão, MAF Grossi… - … of Epidemiology and …, 2011 - jech.bmj.com
In 1997, without strong evidence, the WHO recommended the reduction of multibacillary
(MB) leprosy treatment from 24 to 12 months (it was rated grade D, evidence according to Oxford
Centre). This new disease duration reduction allowed the global elimination target to be ...
Related articles - All 3 versions

美国ACCDON公司旗下品牌

[PDF] Adverse effects of Multi-drug therapy in leprosy, a two years' experience (2006–2008) in tertiary health care centre in the tribal region of Chhattisgarh state ( …

[PDF] Relapse study in smear positive multibacillary (MB) leprosy after 1 year WHO-multi-drug therapy (MDT) in Cebu, Philippines

[PDF] Qualitative Assessment of Medication Adherence at an Urban Leprosy Outpatient Clinic in Hyderabad, India

[PDF] Fighting diseases of poverty

[PDF] Bilateral medial fingernail dystrophy as a presenting feature in a patient with leprosy

[PDF] Adverse effects of Multi-drug therapy in leprosy, a two years' experience (2006–2008) in tertiary health care centre in the tribal region of Chhattisgarh state ( …

[PDF] Relapse study in smear positive multibacillary (MB) leprosy after 1 year WHO-multi-drug therapy (MDT) in Cebu, Philippines

[PDF] Qualitative Assessment of Medication Adherence at an Urban Leprosy Outpatient Clinic in Hyderabad, India

[PDF] Fighting diseases of poverty

[PDF] Bilateral medial fingernail dystrophy as a presenting feature in a patient with leprosy

Increased CXC Ligand 10 Levels and Gene Expression in Type 1 Leprosy Reactions

Genetic Variations and Interactions in Anti-inflammatory Cytokine Pathway Genes in the Outcome of Leprosy: A Study Conducted on a MassARRAY Platform

Specific IgG antibody responses may be used to monitor leprosy treatment efficacy and as recurrence prognostic markers

Human Leukocyte Antigen Class I Region Single-Nucleotide Polymorphisms are Associated with Leprosy Susceptibility in Vietnam and India

Leprosy control: knowledge shall not be neglected